TRANSIENT ISCHEMIC ATTACK COMPREHENSIVE MANAGEMENT AND EVIDENCE BASED APPROACH
Keywords:
transient ischemic attack; ischemic stroke; diffusion-weighted imaging; dual antiplatelet therapy; carotid stenosis; atrial fibrillation; secondary preventionAbstract
Background: Transient ischemic attack (TIA) is a neurological emergency because the risk of ischemic stroke is front-loaded into the first hours and days after symptom onset. Contemporary tissue-based diagnosis, rapid neurovascular imaging, and mechanism-directed prevention have transformed care. Objective: To synthesize current evidence for the diagnosis, risk stratification, acute treatment, disposition, and secondary prevention of TIA. Methods: A targeted structured review of PubMed/MEDLINE and major professional guidance was performed for English-language publications from January 2009 through 12 September 2026. Priority was given to American Heart Association/American Stroke Association and European Stroke Organisation guidance, randomized trials, meta-analyses, and large prospective cohorts involving adults with TIA or minor ischemic stroke. Results: TIA should be defined as transient focal neurological dysfunction caused by cerebral, spinal, or retinal ischemia without acute infarction. Clinical scores may support triage but must not replace brain and vascular imaging or specialist assessment. Magnetic resonance imaging with diffusion-weighted sequences is preferred, while computed tomography combined with head and neck angiography is an effective rapid alternative. For eligible high-risk non-cardioembolic TIA, aspirin plus clopidogrel started early and continued for 21 days provides the most favorable balance of ischemic benefit and bleeding risk. Cardioembolic events require anticoagulation; symptomatic carotid stenosis requires expedited revascularization assessment; and all patients need intensive control of blood pressure, lipids, diabetes, smoking, diet, and physical inactivity. Conclusion: The decisive therapeutic principle is not the disappearance of symptoms but the urgency of identifying the mechanism and starting targeted prevention. A 24-hour diagnostic pathway integrating imaging, cardiac evaluation, and specialist review can prevent a substantial proportion of early strokes.
References
1.Amarenco P, Kim JS, Labreuche J, et al. A comparison of two LDL cholesterol targets after ischemic stroke. N Engl J Med. 2020;382(1):9-19. doi:10.1056/NEJMoa1910355.
2.Amarenco P, Lavallee PC, Labreuche J, et al. One-year risk of stroke after transient ischemic attack or minor stroke. N Engl J Med. 2016;374(16):1533-1542. doi:10.1056/NEJMoa1412981.
3.Amarenco P, Lavallee PC, Labreuche J, et al. Five-year risk of stroke after TIA or minor ischemic stroke. N Engl J Med. 2018;378(23):2182-2190. doi:10.1056/NEJMoa1802712.
4.Amin HP, Madsen TE, Bravata DM, et al. Diagnosis, workup, risk reduction of transient ischemic attack in the emergency department setting: a scientific statement from the American Heart Association. Stroke. 2023;54(3):e109-e121. doi:10.1161/STR.0000000000000418.
5.Bonati LH, Kakkos S, Berkefeld J, et al. European Stroke Organisation guideline on endarterectomy and stenting for carotid artery stenosis. Eur Stroke J. 2021;6(2):I-XLVII. doi:10.1177/23969873211012121.
6.Brazzelli M, Chappell FM, Miranda H, et al. Diffusion-weighted imaging and diagnosis of transient ischemic attack. Ann Neurol. 2014;75(1):67-76. doi:10.1002/ana.24026.
7.Easton JD, Saver JL, Albers GW, et al. Definition and evaluation of transient ischemic attack: a scientific statement from the American Heart Association/American Stroke Association. Stroke. 2009;40(6):2276-2293. doi:10.1161/STROKEAHA.108.192218.
8.Fonseca AC, Merwick A, Dennis M, et al. European Stroke Organisation guidelines on management of transient ischaemic attack. Eur Stroke J. 2021;6(2):CLXIII-CLXXXVI. doi:10.1177/2396987321992905.
9.Gao Y, Chen W, Pan Y, et al. Dual antiplatelet treatment up to 72 hours after ischemic stroke. N Engl J Med. 2023;389(26):2413-2424. doi:10.1056/NEJMoa2309137.
10.Gladstone DJ, Spring M, Dorian P, et al. Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med. 2014;370(26):2467-2477. doi:10.1056/NEJMoa1311376.
11.Hart RG, Sharma M, Mundl H, et al. Rivaroxaban for stroke prevention after embolic stroke of undetermined source. N Engl J Med. 2018;378(23):2191-2201. doi:10.1056/NEJMoa1802686.
12.Johnston SC, Amarenco P, Denison H, et al. Ticagrelor and aspirin or aspirin alone in acute ischemic stroke or TIA. N Engl J Med. 2020;383(3):207-217. doi:10.1056/NEJMoa1916870.
13.Johnston SC, Easton JD, Farrant M, et al. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N Engl J Med. 2018;379(3):215-225. doi:10.1056/NEJMoa1800410.
14.Kleindorfer DO, Towfighi A, Chaturvedi S, et al. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke. 2021;52(7):e364-e467. doi:10.1161/STR.0000000000000375.
15.Merwick A, Albers GW, Amarenco P, et al. Addition of brain and carotid imaging to the ABCD2 score to identify patients at early risk of stroke after transient ischaemic attack. Lancet Neurol. 2010;9(11):1060-1069. doi:10.1016/S1474-4422(10)70240-4.
16.Pan Y, Elm JJ, Li H, et al. Outcomes associated with clopidogrel-aspirin use in minor stroke or transient ischemic attack: a pooled analysis of CHANCE and POINT. JAMA Neurol. 2019;76(12):1466-1473. doi:10.1001/jamaneurol.2019.2531.
17.Perry JJ, Sharma M, Sivilotti MLA, et al. Prospective validation of the ABCD2 score for patients in the emergency department with transient ischemic attack. CMAJ. 2011;183(10):1137-1145. doi:10.1503/cmaj.101668.
18.Rothwell PM, Eliasziw M, Gutnikov SA, et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet. 2003;361(9352):107-116. doi:10.1016/S0140-6736(03)12228-3.
19.Rothwell PM, Giles MF, Chandratheva A, et al. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke: the EXPRESS study. Lancet. 2007;370(9596):1432-1442. doi:10.1016/S0140-6736(07)61448-2.
20.Sanna T, Diener HC, Passman RS, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014;370(26):2478-2486. doi:10.1056/NEJMoa1313600.
21.Wang Y, Wang Y, Zhao X, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013;369(1):11-19. doi:10.1056/NEJMoa1215340.
22.Wang Y, Meng X, Wang A, et al. Ticagrelor versus clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA. N Engl J Med. 2021;385(27):2520-2530. doi:10.1056/NEJMoa2111749.
23.Writing Committee for the PERSIST Collaborators. Long-term risk of stroke after transient ischemic attack or minor stroke: a systematic review and meta-analysis. JAMA. 2025;333(17):1508-1519. doi:10.1001/jama.2025.2033.
